Drug intelligence / Profile preview

tengshen granule

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Tengshen Granule (藤参颗粒) is a traditional Chinese medicine (TCM) preparation under clinical investigation for the treatment of grade 1 hypertension in patients with a specific TCM syndrome pattern characterized by predominant liver heat and yang hyperactivity, and mild kidney yin deficiency. The drug is being evaluated for its safety and efficacy compared to placebo in clinical trials, with the aim of supporting regulatory approval[1]. The exact composition and mechanism of action are not detailed in available public sources. As a TCM product, it likely contains multiple herbal ingredients acting synergistically.

Brand names: 藤参颗粒
Other names: Tengshen Granule藤参颗粒

Beyond the preview

Go deeper on tengshen granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on tengshen granule.

Explore the full profile